Open AccessP13: CAN PATIENT‐REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
Author(s) -
Popat R,
Badros A,
Kumar S,
RodriguezOtero P,
Cohen A,
Manier S,
Voorhees P,
Gay F,
Rifkin R,
Martin T,
Chari A,
Weisel K,
Farooq A,
Jeng B,
Chng W,
Lee H,
Berdeja J,
Jadhav V,
Tosolini A,
Eliason L,
Palumbo A,
Dimopoulos M,
Lonial S,
Trudel S,
Richardson P,
Terpos E
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000829624.40467.0d
Subject(s) - medicine , dosing , refractory (planetary science) , ophthalmology , visual acuity , post hoc analysis , physics , astrobiology